Comparison of five different methods of rubella IgM antibody testing.

le Cubie, H, Edmond, E
Foilsithe 1985

Detection of human papilloma viruses in paraffin wax sections with biotinylated synthetic oligonucleotide probes and immunogold staining.

le Cubie, H A, Norval, M
Foilsithe 1989

A longitudinal study of HPV detection and cervical pathology in HIV infected women

le Cubie, H, Seagar, A, Beattie, G, Monaghan, S, Williams, A
Foilsithe 2000

Humoral antibody response after rubella vaccination.

le Cubie, H A, Burns, S M, Collacott, I T, Lawson, L E
Foilsithe 1985

Lymphoproliferative response to fusion proteins of human papillomaviruses in patients with cervical intraepithelial neoplasia.

le Cubie, H. A., Norval, M., Crawford, L., Banks, L., Crook, T.
Foilsithe 1989

Rubella: immunity and vaccination in schoolgirls.

le Cubie, H A, Burns, S M, Hargreaves, F D, Inglis, J M, Edmond, E, Zealley, H
Foilsithe 1985

Evaluation of a Novel Single-Tube Method for Extended Genotyping of Human Papillomavirus

le Bhatia, R., Serrano, I., Wennington, H., Graham, C., Cubie, H., Boland, E., Fu, G., Cuschieri, K.
Foilsithe in J Clin Microbiol (2018)

Epstein-Barr virus gene expression and epithelial cell differentiation in oral hairy leukoplakia.

le Thomas, J. A., Felix, D. H., Wray, D., Southam, J. C., Cubie, H. A., Crawford, D. H.
Foilsithe 1991

Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study

le Cuschieri, K S, Cubie, H A, Whitley, M W, Gilkison, G, Arends, M J, Graham, C, McGoogan, E
Foilsithe 2005

Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types

le Kavanagh, K, Pollock, K G J, Potts, A, Love, J, Cuschieri, K, Cubie, H, Robertson, C, Donaghy, M
Foilsithe 2014

Use of recombinant human parvovirus B19 antigens in serological assays.

le Cubie, H A, Leslie, E E, Smith, S, O'Neill, H J, Hart, H, Cohen, B J, Inglis, J M
Foilsithe 1993

Rapid real time PCR to distinguish between high risk human papillomavirus types 16 and 18

le Cubie, H A, Seagar, A L, McGoogan, E, Whitehead, J, Brass, A, Arends, M J, Whitley, M W
Foilsithe 2001

Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population

le Cuschieri, K S, Cubie, H A, Whitley, M W, Seagar, A L, Arends, M J, Moore, C, Gilkisson, G, McGoogan, E
Foilsithe 2004

HPV type-specific prevalence using a urine assay in unvaccinated male and female 11- to 18-year olds in Scotland

le O'Leary, M C, Sinka, K, Robertson, C, Cuschieri, K, Lyman, R, Lacey, M, Potts, A, Cubie, H A, Donaghy, M
Foilsithe 2011

Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines

le Cuschieri, K, Brewster, D H, Williams, A R W, Millan, D, Murray, G, Nicoll, S, Imrie, J, Hardie, A, Graham, C, Cubie, H A
Foilsithe 2010

Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland

le Pollock, K G J, Kavanagh, K, Potts, A, Love, J, Cuschieri, K, Cubie, H, Robertson, C, Cruickshank, M, Palmer, T J, Nicoll, S, Donaghy, M
Foilsithe in Br J Cancer (2014)

Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study

le Mesher, D, Szarewski, A, Cadman, L, Cubie, H, Kitchener, H, Luesley, D, Menon, U, Hulman, G, Desai, M, Ho, L, Terry, G, Williams, A, Sasieni, P, Cuzick, J
Foilsithe 2010

Performance of the Xpert HPV assay in women attending for cervical screening

le Cuzick, Jack, Cuschieri, K., Denton, K., Hopkins, M., Thorat, M.A., Wright, C., Cubie, H., Moore, C., Kleeman, M., Austin, J., Ashdown-Barr, L., Hunt, K., Cadman, L.
Foilsithe in Papillomavirus Res (2015)